Literature DB >> 20578942

A novel mutation in the EXT1 gene identified in a Han Chinese kindred with hereditary multiple exostosis.

Wen Wen1, Yang Zhang, Yingbo Wang, Lihua Cao, Shusen Wang, Yang Luo.   

Abstract

Hereditary multiple exostoses (HME) is an autosomal dominant bone disorder characterized by growth of benign multiple exostoses. In our present study, we describe a four-generation Han Chinese kindred with eight members affected by HME. Haplotyping analysis and mutation detection was performed. The results linked the disease-causing gene to the EXT1 locus on chromosome 8. A novel mutation in EXT1, c.1897delC, which cosegregated with the disease phenotype, was detected. To further confirm this mutation, a mismatch primer was designed to introduce a ScaI restriction site into the normal allele by polymerase chain reaction, and the following restriction fragment length polymorphism analysis demonstrated that the mutation was not detected in any unaffected individuals of the family or 100 unrelated Han Chinese control individuals. This mutation leads to a frameshift from codon 633, resulting in a premature termination at codon 642 and loss of the highly conserved C terminal region of the protein. Therefore, this heterozygous mutation must be classified as pathogenic and can be regarded as the cause of HME in this Chinese family.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20578942     DOI: 10.1089/gtmb.2009.0165

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  1 in total

1.  RNA-Seq detects a SAMD12-EXT1 fusion transcript and leads to the discovery of an EXT1 deletion in a child with multiple osteochondromas.

Authors:  Gavin R Oliver; Patrick R Blackburn; Marissa S Ellingson; Erin Conboy; Filippo Pinto E Vairo; Matthew Webley; Erik Thorland; Matthew Ferber; Els Van Hul; Ilse M van der Werf; Wim Wuyts; Dusica Babovic-Vuksanovic; Eric W Klee
Journal:  Mol Genet Genomic Med       Date:  2019-01-10       Impact factor: 2.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.